| Progesterone and 17 alpha-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm. PF Blackmore, SJ Beebe, DR Danforth, N Alexander Journal of Biological Chemistry 265 (3), 1376-1380, 1990 | 592 | 1990 |
| Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone DB Seifer, RT Scott Jr, PA Bergh, LK Abrogast, CI Friedman, CK Mack, ... Fertility and sterility 72 (1), 63-65, 1999 | 271 | 1999 |
| Using virtual reality simulation environments to assess competence for emergency medicine learners JL McGrath, JM Taekman, P Dev, DR Danforth, D Mohan, N Kman, ... Academic Emergency Medicine 25 (2), 186-195, 2018 | 246 | 2018 |
| Dimeric inhibin: a direct marker of ovarian aging DR Danforth, LK Arbogast, J Mroueh, MH Kim, EA Kennard, DB Seifer, ... Fertility and sterility 70 (1), 119-123, 1998 | 242 | 1998 |
| Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients G Barroso, M Barrionuevo, P Rao, L Graham, D Danforth, S Huey, ... Fertility and Sterility 72 (6), 1024-1026, 1999 | 209 | 1999 |
| Inhibin-B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening GE Hofmann, DR Danforth, DB Seifer Fertility and sterility 69 (3), 474-477, 1998 | 147 | 1998 |
| Vascular endothelial growth factor stimulates preantral follicle growth in the rat ovary DR Danforth, LK Arbogast, S Ghosh, A Dickerman, R Rofagha, ... Biology of Reproduction 68 (5), 1736-1741, 2003 | 146 | 2003 |
| Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction CI Friedman, DR Danforth, C Herbosa-Encarnacion, L Arbogast, BM Alak, ... Fertility and sterility 68 (4), 607-612, 1997 | 140 | 1997 |
| Ovarian control of follicle development GF Erickson, DR Danforth American journal of obstetrics and gynecology 172 (2), 736-747, 1995 | 133 | 1995 |
| Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists DR Danforth, LK Arbogast, CI Friedman Fertility and sterility 83 (5), 1333-1338, 2005 | 108 | 2005 |
| Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential CI Friedman, DB Seifer, EA Kennard, L Arbogast, B Alak, DR Danforth Fertility and sterility 70 (5), 836-839, 1998 | 98 | 1998 |
| Development of virtual patient simulations for medical education DR Danforth, M Procter, R Chen, M Johnson, R Heller Journal For Virtual Worlds Research 2 (2), 2009 | 91 | 2009 |
| Contraceptive potential of RU 486 by ovulation inhibition: I. Pituitary versus ovarian action with blockade of estrogen induced endometrial proliferation JFHM van Uem, JG Hsiu, CF Chillik, DR Danforth, A Ulmann, EE Baulieu, ... Contraception 40 (2), 171-184, 1989 | 81 | 1989 |
| Endocrine and paracrine control of oocyte development DR Danforth American journal of obstetrics and gynecology 172 (2), 747-752, 1995 | 80 | 1995 |
| Developing a conversational virtual standardized patient to enable students to practice history-taking skills K Maicher, D Danforth, A Price, L Zimmerman, B Wilcox, B Liston, ... Simulation in Healthcare 12 (2), 124-131, 2017 | 79 | 2017 |
| Non-competitive anti-oestrogenic activity of progesterone antagonists in primate models GD Hodgen, J Van Uem, CF Chillik, DR Danforth, JP Wolf, J Neulen, ... Human Reproduction 9 (suppl_1), 77-81, 1994 | 72 | 1994 |
| Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonist JA Leal, RF Williams, DR Danforth, K Gordon, GD Hodgen The Journal of Clinical Endocrinology & Metabolism 67 (6), 1325-1327, 1988 | 72 | 1988 |
| Using second life virtual simulation environment for mock oral emergency medicine examination J Schwaab, N Kman, R Nagel, D Bahner, DR Martin, S Khandelwal, ... Academic Emergency Medicine 18 (5), 559-562, 2011 | 69 | 2011 |
| Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated … VJ Karnitis, DH Townson, CI Friedman, DR Danforth The Journal of Clinical Endocrinology & Metabolism 79 (1), 91-97, 1994 | 61 | 1994 |
| Cumulative ovulation rate in human menopausal/human chorionic gonadotropin-treated monkeys:“step-up” versus “step-down” dose regimens R Abbasi, D Kenigsberg, D Danforth, RJ Falk, GD Hodgen Fertility and sterility 47 (6), 1019-1024, 1987 | 57 | 1987 |
